Mining disease susceptibility genes through SNP analyses and expression profiling using MALDI-TOF mass spectrometry.
To find genes that underlie disease susceptibilities, genome-wide single nucleotide polymorphisms (SNPs) have been analyzed using high-throughput matrix assisted laser desorption/ionization (MALDI) time-of-flight (TOF) mass spectrometry (MS). As a proof-of-concept for this approach, gene regions have been identified that were previously associated by others with certain diseases or traits. On the same technology platform, accurate and absolute transcriptional profiling can be performed and applied to allele expression analysis. Here, we provide a brief review of the technology and its applications to disease gene discovery.
Tang
Kai
K
Sequenom Inc., 3595 John Hopkins Court, San Diego, California 92121, USA.
Oeth
Paul
P
Kammerer
Stefan
S
Denissenko
Mikhail F
MF
Ekblom
Jonas
J
Jurinke
Christian
C
van den Boom
Dirk
D
Braun
Andreas
A
Cantor
Charles R
CR
D000483:Alleles; D018925:Chemokines / Q000378:metabolism; D018076:DNA, Complementary / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D020022:Genetic Predisposition to Disease; D016678:Genome; D006801:Humans; D010597:Pharmacogenetics; D016133:Polymerase Chain Reaction; D020641:Polymorphism, Single Nucleotide; D020543:Proteome; D040901:Proteomics / Q000379:methods*; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization / Q000379:methods*; D014158:Transcription, Genetic
D018925:Chemokines; D018076:DNA, Complementary; D020543:Proteome